Clearance of JC polyomavirus from cerebrospinal fluid following treatment with interleukin-2 and pembrolizumab in an individual with progressive multifocal leukoencephalopathy and no underlying immune deficiency syndrome.


Journal article


Yasemin Goereci, Finja Schweitzer, Anton Wellstein, Steffi Silling, Sven Borchmann, Bastian von Tresckow, Ortwin Adams, Roland Martin, Mark Schlamann, Michael Schroeter, Gereon R. Fink, Mike P. Wattjes, Clemens Warnke
European Journal of Neurology, 2020 Jun 9

Cite

APA
Goereci, Y., Schweitzer, F., Wellstein, A., Silling, S., Borchmann, S., von Tresckow, B., … Warnke, C. (2020). Clearance of JC polyomavirus from cerebrospinal fluid following treatment with interleukin-2 and pembrolizumab in an individual with progressive multifocal leukoencephalopathy and no underlying immune deficiency syndrome. European Journal of Neurology.

Chicago/Turabian
Goereci, Yasemin, Finja Schweitzer, Anton Wellstein, Steffi Silling, Sven Borchmann, Bastian von Tresckow, Ortwin Adams, et al. “Clearance of JC Polyomavirus from Cerebrospinal Fluid Following Treatment with Interleukin-2 and Pembrolizumab in an Individual with Progressive Multifocal Leukoencephalopathy and No Underlying Immune Deficiency Syndrome.” European Journal of Neurology (June 9, 2020).

MLA
Goereci, Yasemin, et al. “Clearance of JC Polyomavirus from Cerebrospinal Fluid Following Treatment with Interleukin-2 and Pembrolizumab in an Individual with Progressive Multifocal Leukoencephalopathy and No Underlying Immune Deficiency Syndrome.” European Journal of Neurology, June 2020.